Resultats de la cerca - Archie Tse

  • Mostrar 1 - 14 resultats de 14
Refinar resultats
  1. 1
    Potentiation of Cytotoxicity of Topoisomerase I Poison by Concurrent and Sequential Treatment with the Checkpoint Inhibitor UCN-01 Involves Disparate Mechanisms Resulting in Either p53-Independent Clonogenic Suppression or p53-Dependent Mitotic Catastrophe

    Potentiation of Cytotoxicity of Topoisomerase I Poison by Concurrent and Sequential Treatment with the Checkpoint Inhibitor UCN-01 Involves Disparate Mechanisms Resulting in Either... per Archie Tse, Gary K. Schwartz

    Publicat 2004
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Aurora Kinases: New Targets for Cancer Therapy

    Aurora Kinases: New Targets for Cancer Therapy per Richard D. Carvajal, Archie Tse, Gary K. Schwartz

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Targeting Checkpoint Kinase 1 in Cancer Therapeutics

    Targeting Checkpoint Kinase 1 in Cancer Therapeutics per Archie Tse, Richard D. Carvajal, Gary K. Schwartz

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

    Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase per Samuel McNeely, Chiara Conti, Tahir Sheikh, Himali Patel, Sonya Zabludoff, Yves Pommier, Gary K. Schwartz, Archie Tse

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780 per Jayasree S. Nair, Alan L. Ho, Archie Tse, Jesse Coward, Haider Cheema, Grazia Ambrosini, Nicholas Keen, Gary K. Schwartz

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas

    Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro)... per Kevin J. Harrington, Joshua Brody, M. Ingham, James Strauss, Sašo Čemerski, M. Wang, Archie Tse, Anuradha Khilnani, Aurélien Marabelle, Talia Golan

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors

    Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors per Monica Fornier, Dana E. Rathkopf, Manisha H. Shah, S. Patil, Eileen M. O’Reilly, Archie Tse, C. Hudis, Robert A. Lefkowitz, David P. Kelsen, Gary K. Schwartz

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST

    Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST per Gregory Goldmacher, Anuradha Khilnani, Robert H.I. Andtbacka, Jason J. Luke, F. Stephen Hodi, Aurélien Marabelle, Kevin J. Harrington, Andrea Perrone, Archie Tse, David C. Madoff, Lawrence H. Schwartz

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

    CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i> per Archie Tse, Katherine G. Rendahl, Tahir Sheikh, Haider Cheema, Kim Aardalen, Millicent Embry, Sylvia Ma, Edward J. Moler, Zhi Ni, Daniel E. Lopes de Menezes, Barbara Hibner, Thomas G. Gesner, Gary K. Schwartz

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

    Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival per William R. Jarnagin, Lawrence H. Schwartz, David H. Gültekin, Mithat Gönen, Dana Haviland, Jinru Shia, M.I. D’Angelica, Yuman Fong, Ronald P. DeMatteo, Archie Tse, Leslie H. Blumgart, Nancy E. Kemeny

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry per Ki Y. Chung, Jinru Shia, Nancy E. Kemeny, Manish A. Shah, Gary K. Schwartz, Archie Tse, Audrey Hamilton, Dorothy W. Pan, Deborah Schrag, Lawrence B. Schwartz, David S. Klimstra, Daniel Fridman, David P. Kelsen, Leonard B. Saltz

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition

    Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition per Jo Ishizawa, Kenji Nakamaru, Takahiko Seki, Koichi Tazaki, Kensuke Kojima, Dhruv Chachad, Ran Zhao, Lauren Heese, Wencai Ma, Man Chun John, Courtney D. DiNardo, Sherry Pierce, Keyur P. Patel, Archie Tse, R. Eric Davis, Arvind Rao, Michael Andreeff

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

    AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies per Sonya Zabludoff, Chun Deng, Michael Grondine, Adam Sheehy, Susan Ashwell, Benjamin Caleb, Stephen Green, Heather Haye, Candice L. Horn, James W. Janetka, Dongfang Liu, Elizabeth Mouchet, Shannon Ready, Judith L. Rosenthal, Christophe Quéva, Gary K. Schwartz, Karen J. Taylor, Archie Tse, Graeme E. Walker, Anne M. White

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

    Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT) per Aurélien Marabelle, Robert Hans Ingemar Andtbacka, Kevin J. Harrington, Ignacio Melero, Rom S. Leidner, Thierry de Baère, Caroline Robert, Paolo A. Ascierto, Jean‐François Baurain, Michael J. Imperiale, S. Rahimian, Dominique Tersago, E. Klumper, Mathijs P. Hendriks, Rohit Kumar, M. Stern, Katarina Öhrling, Cristian Massacesi, Ilian Tchakov, Archie Tse, Jean-Yves Douillard, Josep Tabernero, John Haanen, Joshua Brody

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: